Gemmotherapy uses the extracts of fresh buds, young shoots, rootlets, or saps from developing plants, where the plant•s life essence is at its peak in the young growths. UNDA Gemmotherapy remedies are prepared in a natural glycerin and organic ethanol medium, which is then filtered and potentized at a 1/10th dilution (1X Hahnemannian) in a pure water, natural glycerin and organic ethanol medium. These complex remedies are macerated for increased patient compliance. This methodology captures the most complete set of highly-concentrated active constituents necessary for tissue regeneration, favourable growth development and essential drainage properties. UNDA Gemmotherapy facilitates Biotherapeutic Drainage• and is an excellent adjunct to the UNDA Numbered Compounds.
Established over half a century ago in Belgium, UNDA is renowned for manufacturing exceptional homeopathic products utilized in supporting immune, lymphatic and endocrine systems. In the production of all homeopathic remedies UNDA uses only pure materials and herbs that are biodynamically grown or wildcrafted. UNDA produces a broad range of homeopathic products in various potencies including: the unique Numbered Compounds, Gemmotherapy macerates, Sch•essler Tissue Salts, Gammadyn Oligo-Elements, Organotherapy, Plexes, creams and oils, as well as homeopathic compatible dental care.
Hawthorn (Crataegus oxyacantha) is a widely used Chinese herb for treatment of gastrointestinal ailments and heart problems and consumed as food. In North America, the role of treatment for heart problems dates back to 1800. Currently, evidence is accumulating from various in vivo and in vitro studies that hawthorn extracts exert a wide range of cardiovascular pharmacological properties, including antioxidant activity, positive inotropic effect, anti-inflammatory effect, anticardiac remodeling effect, antiplatelet aggregation effect, vasodilating effect, endothelial protective effect, reduction of smooth muscle cell migration and proliferation, protective effect against ischemia/reperfusion injury, antiarrhythmic effect, lipid-lowering effect and decrease of arterial blood pressure effect. On the other hand, reviews of placebo-controlled trials have reported both subjective and objective improvement in patients with mild forms of heart failure (NYHA I–III), hypertension, and hyperlipidemia.